01 1Ajinomoto Co., Inc.
02 1KYOWA HAKKO BIO CO., LTD.
03 1Nippon Rika Co., Ltd.
01 3L-Tyrosine
01 3Japan
NDC Package Code : 17333-032
Start Marketing Date : 2017-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12497-1017
Start Marketing Date : 1978-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 52951-002
Start Marketing Date : 1987-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A L-Tyrosine API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Tyrosine API, including repackagers and relabelers. The FDA regulates L-Tyrosine API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Tyrosine API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Tyrosine API manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Tyrosine API supplier is an individual or a company that provides L-Tyrosine API active pharmaceutical ingredient (API) or L-Tyrosine API finished formulations upon request. The L-Tyrosine API suppliers may include L-Tyrosine API API manufacturers, exporters, distributors and traders.
click here to find a list of L-Tyrosine API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Tyrosine API as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Tyrosine API API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Tyrosine API as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Tyrosine API and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Tyrosine API NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Tyrosine API suppliers with NDC on PharmaCompass.
We have 3 companies offering L-Tyrosine API
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
